GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » Operating Margin %

CurveBeam AI (ASX:CVB) Operating Margin % : -397.69% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. CurveBeam AI's Operating Income for the six months ended in Dec. 2023 was A$-13.59 Mil. CurveBeam AI's Revenue for the six months ended in Dec. 2023 was A$3.42 Mil. Therefore, CurveBeam AI's Operating Margin % for the quarter that ended in Dec. 2023 was -397.69%.

The historical rank and industry rank for CurveBeam AI's Operating Margin % or its related term are showing as below:

ASX:CVB' s Operating Margin % Range Over the Past 10 Years
Min: -397.69   Med: -161.61   Max: -105.92
Current: -397.69


ASX:CVB's Operating Margin % is ranked worse than
87.98% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 0.85 vs ASX:CVB: -397.69

CurveBeam AI's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

CurveBeam AI's Operating Income for the six months ended in Dec. 2023 was A$-13.59 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was A$-13.59 Mil.


CurveBeam AI Operating Margin % Historical Data

The historical data trend for CurveBeam AI's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI Operating Margin % Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23
Operating Margin %
-105.92 -161.61 -232.85

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23
Operating Margin % - -146.29 -173.63 - -397.69

Competitive Comparison of CurveBeam AI's Operating Margin %

For the Medical Devices subindustry, CurveBeam AI's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CurveBeam AI's Operating Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's Operating Margin % distribution charts can be found below:

* The bar in red indicates where CurveBeam AI's Operating Margin % falls into.



CurveBeam AI Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

CurveBeam AI's Operating Margin % for the fiscal year that ended in Jun. 2023 is calculated as

Operating Margin %=Operating Income (A: Jun. 2023 ) / Revenue (A: Jun. 2023 )
=-18.756 / 8.055
=-232.85 %

CurveBeam AI's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-13.593 / 3.418
=-397.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CurveBeam AI  (ASX:CVB) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


CurveBeam AI Operating Margin % Related Terms

Thank you for viewing the detailed overview of CurveBeam AI's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


CurveBeam AI (ASX:CVB) Business Description

Traded in Other Exchanges
N/A
Address
10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.

CurveBeam AI (ASX:CVB) Headlines

No Headlines